Study TO Prevent Noninsulin Dependent Diabetes Mellitus trial - STOP-NIDDM

Description:

The goal of the STOP-NIDDM trial was to evaluate the effect of decreasing postprandial hyperglycemia with acarbose, an alpha-glucosidase inhibitor, on the risk of diabetes, cardiovascular (CV) disease, and hypertension in patients with impaired glucose tolerance (IGT).